Clinical Trial Update: Type 2 Innate Lymphoid Cells in Severe Pediatric Asthma

View source ↗

Summary

Clinical trial investigating Type 2 Innate Lymphoid Cells in severe pediatric asthma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Severe Asthma | Status: WITHDRAWN